Project Description

T-REXOME is Tailored Therapeutics’ platform that enables development of deep genomic insights into the patient’s immune system tumor response.  T-REXOME leverages next-generation genomic sequencing to analyze the patients healthy and cancer tissue to identify mutations in the tumor.  Armed with insights into the exact T-cells responsible for fighting the tumor, scientists at Tailored Therapeutics can engineer specialized T-cells to express the receptor or enrich tumor reactive cells to fight the tumor.